BRIGHT MINDS BIOSCIENCES INC (DRUG)

CA10919W4056 - Common Stock

39.88  -0.3 (-0.75%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023
Revenue
YoY % growth
EBITDA
YoY % growth
N/AN/AN/A-14.967M-7.294M
51.26%
EBIT
YoY % growth
-78.72K-480.38K
-510.24%		-8.805M
-1,732.89%		-14.973M
-70.05%		-7.367M
50.80%
Operating Margin
N/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A